CD274 and obesity due to melanocortin 4 receptor deficiency: The influence of obesity on the PD-1/PDL-1 axis may explain its unexpected benefits on the efficacy of immunotherapy in cancer patients [249], although other work has not confirmed such benefits and larger more in-depth prospective trials are needed to clarify any potential benefit [250].